Wixela vs Flovent
What to choose Wixela or Flovent
Wixela and Flovent are inhalers both of Control type. Wixela and Flovent are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Flovent is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Flovent is Fluticasone. The available dosages for Flovent are 44 mcg, 110 mcg, 220 mcg.
The average cost for Wixela is roughly $240 per inhaler while current price for Flovent is around $198 per inhaler, said Arjun Howard, a Scientist at the Concordia University River Forest, Illinois and a Medical Director at a clinic that uses Wixela and Flovent.
Wixela and Flovent Comparison
|Substance:||Fluticasone + Salmeterol||Fluticasone|
|Dosage:||250/50||44 mcg, 110 mcg, 220 mcg|